Skip to main content
. 2022 Nov 30;15:2243–2255. doi: 10.2147/RMHP.S391386

Table 4.

Univariate Logistic Regression Analysis of Risk Factors for Patients with OLGA/OLGIM III–IV

Risk factors OLGA I–II VS OLGA III–IV OLGIM I–II VS OLGIM III–IV
OLGA I–II (n = 448) OLGA III–IV (n = 161) p-value OR (95% CI) OLGIM I–II (n = 370) OLGIM III–IV (n = 157) p-value OR (95% CI)
Gender, Male, n (%) 265 (59.15) 94 (58.39) 0.865 0.969 (0.672–1.397) 200 (54.05) 83 (52.87) 0.803 0.953 (0.658–1.386)
Age, years, mean (SD) 51.33 (9.78) 51.10 (10.30) 0.798 0.998 (0.980–1.016) 49.79 (9.58) 53.29 (10.39) <0.001 1.036 (1.017–1.057)
BMI, kg/m², mean (SD) 24.32 (2.92) 24.16 (2.90) 0.545 0.981 (0.922–1.044) 24.09 (3.27) 23.97 (3.28) 0.712 0.989 (0.934–1.048)
Smoking, n (%) 185 (41.29) 68 (42.24) 0.835 1.039 (0.722–1.497) 161 (43.51) 64 (40.76) 0.560 0.893 (0.612–1.305)
Alcohol consumption, n (%) 191 (42.63) 71 (44.10) 0.747 1.061 (0.738–1.526) 170 (45.95) 69 (43.95) 0.674 0.922 (0.634–1.343)
Family history, n (%) 34 (7.59) 26 (16.15) 0.002 2.345 (1.358–4.050) 30 (8.11) 28 (17.83) 0.001 2.460 (1.414–4.279)
H. pylori infection, n (%) 172 (38.39) 87 (54.04) 0.001 1.887 (1.311–2.714) 121 (32.70) 84 (53.50) <0.001 2.368 (1.617–3.468)
PGI, µg/L Median (IQR) 107.05 (79.49–141.21) 79.53 (64.36–107.90) <0.001 0.986 (0.981–0.990) 101.97 (78.42–132.98) 85.31 (62.33–122.29) 0.019 0.995 (0.992–0.999)
PGII, µg/L Median (IQR) 10.35 (6.57–17.80) 9.92 (6.45–14.73) 0.283 0.989 (0.970–1.009) 8.50 (6.01–13.04) 13.84 (7.68–20.81) <0.001 1.055 (1.034–1.076)
PGR, Median (IQR) 10.58 (7.34–17.02) 8.01 (5.86–12.64) <0.001 0.925 (0.888–0.964) 11.89 (8.73–14.87) 6.67 (4.98–9.13) <0.001 0.739 (0.695–0.787)
G-17, pmol/L Median (IQR) 2.85 (1.33–7.05) 3.06 (1.54–9.52) 0.040 1.015 (1.001–1.029) 2.37 (1.28–5.89) 4.32 (2.06–14.38) <0.001 1.062 (1.040–1.085)

Abbreviations: PGI, serum pepsinogen I; PGII, serum pepsinogen II; PGR, pepsinogen I and II ratio; G-17, gastrin-17; BMI, body mass index; SD, standard deviation; IQR, interquartile range.